Skip to main content
HR 6433 110th Congress House Health Administrative fees Administrative procedure Animals Appropriations Authorization Commerce Congress Congressional reporting requirements Department of Health and Human Services Drug approvals Drug industry Economics and Public Finance Electronic government information Food and Drug Administration (FDA) Generic drugs Government Operations and Politics Government publicity Law Pharmaceutical research

Animal Generic Drug User Fee Act of 2008

Introduced: July 8, 2008 Introduced by: Pallone, Frank Democratic · New Jersey See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 30, 2008
Placed on the Union Calendar, Calendar No. 521.
Jul 30, 2008
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-805.
Jul 16, 2008
Ordered to be Reported (Amended) by Voice Vote.
Jul 16, 2008
Committee Consideration and Mark-up Session Held.
Jul 9, 2008
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jul 9, 2008
Subcommittee Consideration and Mark-up Session Held.
Jul 8, 2008
Referred to the Subcommittee on Health.
Jul 8, 2008
Referred to the House Committee on Energy and Commerce.
Jul 8, 2008
Introduced in House
 Plain-English summary Congressional Research Service

Animal Generic Drug User Fee Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.

Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.

Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.

Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.

Authorizes appropriations for FY2009-FY2013.

Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.

Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.

Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014.

What's happening now July 30, 2008

Placed on the Union Calendar, Calendar No. 521.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1